NewswireToday - /newswire/ -
Philadelphia, PA, United States, 2011/07/11 - Greenphire, has announced the launch of its Clinical GPS technology, a unique site payment solution that streamlines and automates the clinical payment process for sponsors of all sizes - Greenphire.com.
Greenphire, the industry leading provider of clinical payment and communication technology solutions, has announced the launch of its Clinical GPS technology, a unique site payment solution that streamlines and automates the clinical payment process for sponsors of all sizes. The system provides the ultimate solution for compliance with the recently passed federal Physician Payment Sunshine Act, enabling clients to make the required disclosures and reports effortlessly.
The Physician Payment Sunshine Act requires sponsor companies to record any physician payments that are worth more than $10 in 2012 and report them on March 31st, 2013. The details of payment will be posted in a searchable database starting September 30th, 2013. Failure to include information can lead to significant penalties, with inaccurate reports impacting a company’s ongoing relationship with healthcare providers. The new legislation poses a significant challenge to companies who do not already have a data capture process in place. Technical solutions may need to be devised, implemented and tested well in advance of the upcoming data collection date.
Greenphire’s Clinical GPS solution utilizes a proprietary validation engine that is capable of analyzing data and triggering payments to a recipient based on customizable terms negotiated within a contract. The system is designed to integrate with EDC, IVRS, CTMS and any other clinical computer system in order to automate the triggering of payments to sites, investigators and vendors involved with a clinical study. By centralizing all payment activity through a technology driven system, Clinical GPS is capable of providing detailed reporting at the site, investigator and vendor level for a single study or across a number of studies. The system not only benefits sponsors and ensures compliance with the Sunshine Act, but ultimately facilitates a quicker and more efficient payment process to CROs.
Samuel Whitaker, CEO at Greenphire comments: “Currently we are the only company to offer a centralized reporting and auditing tool for clinical trial payments. The strategic release of the Clinical GPS solution to coincide with the passing of the Sunshine Act demonstrates Greenphire’s position as an innovative leader in developing clinical payment solutions and communication technology solutions. Greenphire works to monitor developments within the clinical sector and creates leading technology that anticipates the needs of the customer.”
For further information on Greenphire and its innovative solutions please email sales[.]greenphire.com, call +1 215-609-4640.
Greenphire (greenphire.com) is the industry leading provider of web-based patient payment, management and communication technology for the clinical trial environment.
It has developed technologies that are designed to be implemented globally in order to improve operational efficiency, reduce costs, mitigate regulatory risks, increase subject retention, promote protocol compliance and produce quantifiable results for our clients in the pharmaceutical, biotechnology, medical device, academic and life sciences industries.